PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Over-the-counter medication · Calcium Supplement / Antacid

calcium carbonate

Also sold as Tums, Caltrate, Os-Cal. This medicine treats heartburn, sour stomach, acid indigestion, and upset stomach.

Data updated 2026-05-15

64,404
FDA reportsOften reported
1
InteractionFew interactions
In shortage
FDA status

What the data shows

calcium carbonate (Tums) is an over-the-counter Calcium Supplement / Antacid, more reported than most tracked drugs (64,404 FDA reports), with 1 documented drug interaction.

Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.

calcium carbonate (Tums) is an over-the-counter Calcium Supplement / Antacid. This medicine treats heartburn, sour stomach, acid indigestion, and upset stomach.

Calcium carbonate is a medicine that can relieve heartburn and upset stomach. It is also used as a calcium supplement.

Drug Shortage Alert

calcium carbonate is currently listed as to be discontinued by the FDA. Affected manufacturer: Hospira, Inc., a Pfizer Company.

View all drug shortages →

Drug Pricing (NADAC)

Generic Price

$0.17/unit

Generic Available

Yes (23 manufacturers)

Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →

View Alternatives → Compare with Another Drug → Full Side Effects Report →

What it does

This medicine treats heartburn, sour stomach, acid indigestion, and upset stomach.

Common side effects

Nausea, Diarrhea, Headache

Key warnings

Do not take more than 4 tablets in 24 hours.

The sections below are summarized in plain English from calcium carbonate's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.

How It Works

Calcium carbonate is an antacid. It works by neutralizing stomach acid. This helps to relieve heartburn and indigestion.

How to Take It

Take one to four tablets each day. Do not take more than 4 tablets in 24 hours. Do not use the highest dose for more than 2 weeks. Follow the directions on the package.

This is a plain-language summary of calcium carbonate's FDA labeling, not individualized dosing advice. Ask a pharmacist or prescriber before changing how you take this medication.

Pregnancy & Breastfeeding

Ask your doctor if it is safe to take this medicine while pregnant or breastfeeding. Calcium carbonate may pass into breast milk.

This is a plain-language summary of calcium carbonate's FDA labeling, not individualized advice. Ask a pharmacist or prescriber about pregnancy or breastfeeding on this medication.

Missed Dose

If you miss a dose, take it as soon as you remember. Do not take more than 4 tablets in one day.

This is a plain-language summary of calcium carbonate's FDA labeling, not individualized advice. Ask a pharmacist or prescriber what to do about your specific missed dose.

Storage

Store at room temperature away from moisture and heat.

Side Effects (from patient reports)

Based on 64,404 FDA adverse event reports.

Most-reported reactions

Adverse reactions in FAERS for calcium carbonate, by number of reports

reports

What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.

Source FDA Adverse Event Reporting System (FAERS) As of 2025

Reports over time

Adverse-event reports filed for calcium carbonate each year to the FDA Adverse Event Reporting System (FAERS).

-2,00002,0004,0006,0008,000 200220052008201120142017202020232025 5,100

Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.

Where calcium carbonate sits

calcium carbonate has more FDA adverse-event reports than 78% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.

fewest reports most reports

Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is calcium carbonate; the line is the median (50th percentile).

FDA Adverse Event Report Analysis

Detailed analysis of 64,404 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2002–2025.

Total Reports

64,404

Reports Mentioning Death

8,716

13.5% of reports — not proof of cause

Hospitalization Reports

27,035

Top Indication

Product Used For Unknown Indication

Gender Distribution

Female 39,878 (67%)
Male 19,397 (33%)

Age Distribution

0–17 1,542
18–44 7,018
45–64 13,889
65–74 10,128
75+ 9,334

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
1 FATIGUE 6,169
2 NAUSEA 5,635
3 DIARRHOEA 4,987
4 CHRONIC KIDNEY DISEASE 4,954
5 PAIN 4,920
8 DYSPNOEA 4,648
9 VOMITING 4,414
10 HEADACHE 4,195
11 PNEUMONIA 3,743
12 ACUTE KIDNEY INJURY 3,708
13 ARTHRALGIA 3,708
14 MALAISE 3,588
15 PYREXIA 3,406
16 DIZZINESS 3,245
17 ASTHENIA 3,239

Reactions in Death Reports

DEATH 2,195
FATIGUE 1,498
HYPERTENSION 1,443
GENERAL PHYSICAL HEALTH DETERIORATION 1,430
TYPE 2 DIABETES MELLITUS 1,341
RHEUMATOID ARTHRITIS 1,338
SYSTEMIC LUPUS ERYTHEMATOSUS 1,335
VOMITING 1,322
HYPOAESTHESIA 1,309
INFUSION RELATED REACTION 1,298

Reactions in Hospitalization Reports

NAUSEA 3,166
FATIGUE 3,019
VOMITING 2,934
DYSPNOEA 2,836
PNEUMONIA 2,805
DIARRHOEA 2,743
PAIN 2,654
PYREXIA 2,508
MALAISE 2,341
HEADACHE 2,288

Source: FDA FAERS (Adverse Event Reporting System) FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

Do not take more than 4 tablets in 24 hours. Do not use the maximum dosage for more than 2 weeks.

Known Drug Interactions

Drug or Drug Class Effect Phosphate Binders (e.g., calcium carbonate, ferrous sulfate, sevelamer, lanthanum) Phosphate binders may bind to levothyroxine. Drug or Drug Class Effect Phosphate Binders (e.g., calcium carbonate, ferrous sulfate, sevelamer, lanthanum) Phosphate binders may bind to levothyroxine.

Mechanism: Calcium carbonate can bind to levothyroxine in your gut, making it harder for your body to soak up the thyroid medicine.

What to do: You should separate the timing of these doses by several hours to ensure your body gets enough thyroid hormone.

This is a plain-language summary of interactions documented in FDA labeling, not individualized advice. Ask a pharmacist or prescriber before combining medications.

Common Questions

What is calcium carbonate used for?
It is used to relieve heartburn, sour stomach, acid indigestion, and upset stomach. It can also be used as a calcium supplement.
How many tablets can I take each day?
Do not take more than 4 tablets in 24 hours.
Can I take this medicine every day?
Yes, but do not use the maximum dosage for more than 2 weeks.
Can I take this while pregnant?
Ask your doctor if it is safe to take this medicine while pregnant.
What should I do if I miss a dose?
Take it as soon as you remember. Do not take more than 4 tablets in one day.
How should I store this medicine?
Store at room temperature away from moisture and heat.
Does this medicine have side effects?
Common side effects include nausea, diarrhea, and headache.
Can I take this with other medicines?
Talk to your doctor or pharmacist before taking this with other medicines.
Is this the same as Tums?
Yes, Tums is a brand name for calcium carbonate.
Is this the same as Caltrate?
Yes, Caltrate is a brand name for calcium carbonate.
What are the common side effects of calcium carbonate?
The most commonly reported side effects of calcium carbonate include Nausea, Diarrhea, Headache. Based on 64,404 FDA adverse event reports. Always consult your healthcare provider about potential side effects.
Does calcium carbonate interact with other medications?
Yes, calcium carbonate has 1 known drug interactions. Notable interactions include levothyroxine. Always inform your doctor about all medications you are taking.
What drug class is calcium carbonate?
calcium carbonate belongs to the Calcium Supplement / Antacid drug class. It is available over the counter (OTC). This medicine treats heartburn, sour stomach, acid indigestion, and upset stomach.
Is calcium carbonate safe during pregnancy?
Ask your doctor if it is safe to take this medicine while pregnant or breastfeeding. Calcium carbonate may pass into breast milk. Always consult your healthcare provider before using any medication during pregnancy or breastfeeding.
Has calcium carbonate been recalled?
There are 25 recalls associated with calcium carbonate products. Presence of foreign substance: small metallic particles in chewable tablets. Check the recalls section below for full details and affected products.
Is calcium carbonate currently in shortage?
Yes, calcium carbonate is currently listed as to be discontinued by the FDA. Affected manufacturer: Hospira, Inc., a Pfizer Company. Visit the FDA Drug Shortages database for the latest updates.

Active Recalls

Class II May 28, 2026

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

Class II May 28, 2026

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

Class II May 28, 2026

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

Class II May 28, 2026

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

Class II May 28, 2026

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

Class II May 28, 2026

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

Class II May 28, 2026

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

Class II May 28, 2026

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

Class II May 28, 2026

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

Class II May 28, 2026

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

Class II May 28, 2026

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

Class II May 28, 2026

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

Class II May 28, 2026

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

Class II May 28, 2026

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

Class II May 28, 2026

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

Class II May 28, 2026

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

Class II May 28, 2026

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

Class II May 28, 2026

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

Class II May 28, 2026

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

Class II May 28, 2026

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

Class II May 28, 2026

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

Class II May 28, 2026

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

Class II May 28, 2026

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

Class II December 26, 2025

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

GOLD STAR DISTRIBUTION INC

Class II November 11, 2024

cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.

Safecor Health, LLC

Related Medications in Calcium Supplement / Antacid

Other drugs grouped near calcium carbonate - same-class peers and common alternatives.

Compare calcium carbonate vs ascorbic acid side-by-side →

Medication Guides

What the FDA Data Shows for calcium carbonate

The FDA label for calcium carbonate (sold under brand names such as Tums, Caltrate, Os-Cal) classifies it as an over-the-counter product in the Calcium Supplement / Antacid class. This medicine treats heartburn, sour stomach, acid indigestion, and upset stomach. Official labeling lists 3 commonly reported side effects, including Nausea, Diarrhea, Headache.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 64,404 voluntary reports. The database also lists 1 documented drug interaction derived from FDA labeling, with the top-flagged interaction rated minor severity. NADAC pricing from CMS shows a generic unit cost of $0.17.

Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history (currently 25 recall records on file), and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice, always consult a licensed healthcare provider before starting, stopping, or changing any medication.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC). Shortage status: FDA Drug Shortages Database.

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.

Last updated: December 22, 2017

Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled and last refreshed May 2026. See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

All federal data sources used on this page